drugset / Trial / NCT06457204
A Study in Healthy People to Compare Two Different Sifrol® Tablets
RandomizedCrossoverOpen-labelTreatment
Summary
The main objective of this trial is to establish the bioequivalence of Sifrol® tablets manufactured at two different sites.
Timeline
- Start
- 2024-07-02
- Primary completion
- 2024-08-12
- Completion
- 2024-08-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Pramipexole | Unknown | 0.088 mg | Oral |
Indications
No indication recorded.